Loading...
NPI 1548208440 · Pendleton, OR · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Interpath Laboratory, Inc. is a clinical medical laboratory provider located in Pendleton, Oregon. This profile covers 360 Medicare and 333 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Interpath Laboratory, Inc. |
| Address | 2460 Sw Perkins Avenue |
| City | Pendleton |
| State | OR |
| ZIP | 97801 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | June 3, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $70M |
| Medicare | $7.8M |
INTERPATH LABORATORY, INC. is a high-volume clinical diagnostic lab with a clear Medicaid emphasis: lifetime Medicaid revenue is $70M compared with total Medicare revenue of $7.8M, indicating the bulk of billings and revenue flow through state programs rather than Medicare. The provider’s NPI was enumerated on 2006-06-03 (~20 years ago), consistent with an established laboratory operation rather than a recent entrant.
The provider’s Medicare book is concentrated in a small set of routine clinical and anatomic lab services: the top three Medicare codes account for 35.6% of total Medicare revenue and include high-volume chemistry and collection codes such as 80053, 80061 and 36415. Those three codes (80053: 73.3K claims, $733.3K revenue; 80061: 51.2K claims, $665K revenue; 36415: 82.8K claims, $662.6K revenue) point to core services of panel testing and specimen collection as primary Medicare revenue drivers.
Medicaid revenue shows a similar concentration but with a different service mix: the top three Medicaid codes account for 37.5% of total Medicaid revenue and are led by high-throughput infectious disease and screening panels including U0004, 80050 and 87591 (U0004: 126.4K claims, $8.7M revenue; 80050: 187.7K claims, $5.6M revenue; 87591: 118.2K claims, $3.4M revenue). The prominence of U0004 (COVID PCR, $8.7M, 18.4% of Medicaid revenue) and large volumes for 87591/87491 indicate substantial molecular/NAAT capacity aimed at infectious disease testing for Medicaid patients.
INTERPATH is clearly a market leader on code-level benchmarks: multiple Medicare codes are described as “extreme outlier” nationally (for example 80053 ranks #52 of 26416 providers nationally, 80061 ranks #45 of 21671, and 36415 ranks #52 of 86467), while many Medicaid codes rank #1 in-state (for example U0004 #1 of 8, 80050 #1 of 19, 87591 and 87491 each #1 of 72). These rank and percentile signals indicate the lab is a dominant statewide player for a wide range of common testing codes and an above-typical-volume provider even at the national level for core Medicare panel and collection services.
The service mix combines high-volume low-paid encounters with higher-priced molecular tests: Medicaid shows massive claim counts with low per-claim payments for specimen/collection and routine panels (e.g., 36415: 514.2K claims, $3 avg paid/claim, $1.5M revenue; 85025: 311.1K claims, $5 avg paid/claim, $1.6M revenue) alongside high-revenue molecular/NAAT lines (e.g., U0004: $8.7M revenue). On Medicare, similarly large claim volumes for routine panels and analytes (for example 80053, 80061, 85025 and 83036) demonstrate operational emphasis on throughput and automated chemistry/immunoassay testing.
Molecular infectious-disease and sexual-health testing are material parts of Medicaid revenue, suggesting reference-laboratory capabilities beyond basic chemistry: in addition to U0004, high Medicaid revenues appear for 87389 (HIV screening: 75.7K claims, $1.5M revenue), 87491 and 87591 (Chlamydia/GC NAATs: both ~118K claims, $3.4M revenue each), 87661 (Trichomonas: 43.7K claims, $1.2M revenue) and 87624 (HPV: 36.3K claims, $1M revenue). These code-level patterns imply commercial-scale molecular testing and programmatic contracts for public-health screening or partner clinics.
Both payers show revenue concentration risk at the code level: the precomputed metrics show the top 3 Medicare codes make up 35.6% of Medicare revenue and the top 3 Medicaid codes make up 37.5% of Medicaid revenue, indicating reliance on a relatively narrow set of high-volume tests. Given the provider’s dominant in-state rankings and large claim volumes (many described as “extreme outlier” or “notably above typical state volume”), changes in reimbursement or test mix for those top codes could disproportionately affect overall revenue.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
360 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 73,330 | $10 | $733.3K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 51,150 | $10 | $665K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 82,820 | $10 | $662.6K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 41,190 | $20 | $659.1K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 65,440 | $10 | $523.5K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 11,320 | $30 | $328.3K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 34,590 | $10 | $311.3K |
| 84153 | The lab analyst performs testing for total prostate specific antigen, PSA, typically on serum or plasma samples using laboratory analyzers. PSA is a protein the prostate gland produces, and… | 9,280 | $20 | $167K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 4,010 | $40 | $160.3K |
| 84439 | The lab analyst performs a test to measure free thyroxine, or free T4, typically in patient serum. | 15,860 | $10 | $142.8K |
Showing 1–10 of 360
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 360 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
360 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 81513 | 1 | 10 | 690 | $140 | $95.9K |
| G0480 | 3 | 20 | 130 | $110 | $44.9K |
| 86481 | 2 | 10 | 270 | $100 | $25.9K |
| 88305 | 43 | 270 | 200 | $30 | $21.4K |
| G0471 | 1 | 10 | 1,840 | $10 | $19.1K |
| 83013 | 1 | 10 | 270 | $70 | $17.8K |
| 83704 | 1 | 10 | 500 | $30 | $16.8K |
| 88185 | 3 | 10 | 1,090 | $20 | $15.9K |
| 80307 | 2 | 50 | 110 | $60 | $13.6K |
| 86235 | 1 | 10 | 390 | $20 | $12.6K |
Showing 1–10 of 360
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
333 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 126,450 | $70 | $8.7M |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 187,680 | $30 | $5.6M |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 118,190 | $30 | $3.4M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 118,100 | $30 | $3.4M |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 265,930 | $10 | $2.4M |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 183,560 | $10 | $2M |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 267,950 | $10 | $1.9M |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 35,610 | $40 | $1.6M |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 311,130 | $10 | $1.6M |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 514,170 | $1 | $1.5M |
Showing 1–10 of 333
How this provider's Medicaid billing volume and revenue compare to other Oregon providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Oregon median
333 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 1 | 10 | 1,790 | $60 | $1.8M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 6 | 60 | 420 | $60 | $405.1K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 12 | 10 | 290 | $90 | $379.1K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 1 | 20 | 780 | $30 | $360.1K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 4 | 80 | 1,210 | $40 | $294.3K |
| 86481 | The lab analyst performs a test to evaluate an antigen response to certain tuberculosis (TB) antibodies by enumerating T cells that produce gamma interferon. | 1 | 10 | 3,160 | $60 | $292.3K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 15 | 90 | 530 | $50 | $281.6K |
| 87632 | The lab analyst performs a test to identify a respiratory virus using an amplified nucleic acid probe technique. He may also use the multiplex reverse transcription technique. The provider does this… | 1 | 10 | 1,570 | $160 | $258.1K |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 1 | 10 | 390 | $120 | $240.6K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 3 | 10 | 1,520 | $100 | $218.3K |
Showing 1–10 of 333
Other providers in the same ZIP code as Interpath Laboratory, Inc., ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Pendleton House | OR | Mental Illness Community Based Residential Treatment Facility | $0 | $17.9M |
| Commonspirit Oregon | OR | Critical Access Hospital | $0 | $13.7M |
| Eastern Oregon Alcoholism Foundation | OR | Substance Abuse Rehabilitation Facility | $0 | $9.9M |
| Yellowhawk Tribal Health Center | OR | Clinic/Center | $0 | $5.1M |
| Jeffrey Kobernik | OR | General Practice Dentistry | $0 | $1.9M |
| City Of Pendleton | OR | Land Ambulance | $529K | $1.1M |
| Umatilla River Emergency Physicians LLC | OR | Emergency Medicine Physician | $0 | $1.5M |
| Joshua Garren | OR | Radiation Oncology Physician | $1.3M | $0 |
| Case Ketting | OR | Radiation Oncology Physician | $325.1K | $0 |
| Terrol Marshall | OR | Podiatrist | $209.8K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.